Index.

961Bulletin of the World Health Organization | December 2004, 82 (12) Index Bulletin of the World Health Organization, Volume 82, 2004 Subject Index A Accessing health care: responding to diversity (Healey & McKee) 882 acquired immune deficiency syndrome see AIDS adherence, fixed-dose combination pills vs unit-of-use packaging 935–939 Advances in insect chemical ecology (Cardé & Millar) 955 adverse events health care-related, global campaign 889, 892 immunization-related, reporting in Europe 828–835 advocacy, patient, and arthritis 115–120 affective disorders, treatment gap 858–866 Afghanistan health-care services 712–713 latrine revision programme 281–289 Africa 3-by-5 initiative for HIV/AIDS 77–78 antiretroviral treatment scale-up 798–800 averting a malaria disaster 381–384 compensation for medical brain drain 633 gender issues in HIV/AIDS control 812 HIV serostatus disclosure among women 299–307 insecticide-treated nets for malaria control 84, 85–91, 884–886 natural history of HIV infection in adults 462–469 polio cases 394, 557, 717 polio immunization campaign 237–238, 890 projected diabetes burden 397–398 secondary prevention of stroke 503–508 sexual abuse of women and children 313 WHO Regional Director 717–718, 809 ageing, population see population ageing aid, international see international aid AIDS 3-by-5 initiative for developing countries 77–78, 474–476 de-listing of approved generic drugs 633, 718 drug therapy see antiretroviral therapy international conference 713 natural history in adults in Africa 462–469 new initiative involving UN and broadcasters 232–233 red ribbon banned in Zimbabwe 633 treatment and prevention 400 treatment programme in South Africa 73–74 vaccine see HIV, vaccine see also HIV AIDS International Training and Research Program (AITRP) 616–623 albendazole, mass treatment in Brazil 563–571 alcohol-related problems in developing countries 641 treatment gap 858–866 alternative medicines, guidelines 635–636 Americas laboratory diagnosis of measles 852–857 mental health care treatment gap 858–866 progress towards measles eradication 134–138 vaccination campaign 398 antenatal care syphilis detection and management see pregnancy, syphilis during in Thailand 746–749 anthelminthic therapy children in Cambodia 636 mass treatment in Brazil 562, 563–571 The anthrax letters: a medical detective story (Cole) 71–72 anti-hypertensive therapy, stroke survivors in southern Africa 503–508 anti-tuberculous drugs DOTS, in China 716 free, for developing countries 79 public–private mix for DOTS implementation 580–586 spread of resistance in Europe and Asia 313 antibiotics (antimicrobials) for childhood illness, training health workers 509–515 maternal syphilis 401, 433–438 resistance containment and surveillance approach 928–934 antimalarial drugs costs of effective, in Africa 381–384 see also artemisinin combination therapy antiretroviral therapy de-listing of approved generic drugs 633, 718 feasibility of scale-up, in Africa 798–800 preparedness 959 survival of HIV-infected adults in Africa and 462–469 anxiety disorders, treatment gap 858–866 Argentina, residual spraying against Triatoma infestans 196–205 Arrow, Kenneth, and birth of health economics 139–140 artemisinin combination therapy (ACT) barriers to implementation 237, 473 economics in Africa 381–384 supply problems 959 arthritis, patient advocacy and 115–120 Asia, drug-resistant TB 313 asthma, in early childhood, in Brazil 516–522 Australia, nurse migration to 587–594 B Bangladesh, community participation in health impact assessment 881 BBC television, series on developing-country diseases 473 BCG vaccine duration of protection 555 in leprosy scenario analysis 373–380 Bill and Melinda Gates Foundation 718 bipolar disorder, treatment gap 858–866 birth interval, infant and child mortality and, in Burkina Faso 265–273 blindness glaucoma-related 887–888 global data for 2002 844–851 blood supplies, safe, in developing countries 558 Bolivia antenatal syphilis control programme 410–416 medicinal plant and pharmaceutical use by indigenous communities 243–250 books and electronic media Accessing health care: responding to diversity (Healey & McKee) 882 Advances in insect chemical ecology (Cardé & Millar) 955 The anthrax letters: a medical detective story (Cole) 71–72 Child public health (Blair et al) 150 Circles of recovery: self-help organizations for addictions (Humphreys) 390 Continent of mothers. Continent of hope. Understanding and promoting development in Africa today (Skard) 71 Ethical and regulatory aspects of clinical research: readings and commentary (Emanuel et al) 551 Evidence-based public health (Brownson et al) 308 No. 1, January 2004, 1–81 No. 2, February 2004, 82–159 No. 3, March 2004, 160–238 No. 4, April 2004, 239–318 No. 5, May 2004, 319–398 No. 6, June 2004, 399–478 No. 7, July 2004, 479–558 No. 8, August 2004, 559–638 No. 9, September 2004, 639–718 No. 10, October 2004, 719–810 No. 11, November 2004, 811–890 No. 12, December 2004, 891–970 962 Bulletin of the World Health Organization | December 2004, 82 (12) Index Food fight: the inside story of the food industry, America’s obesity crisis, and what can be done about it (Brownell & Horgen) 308–309 Global public health: a new era (Beaglehole) 150–151 Guide de gestion des mutuelles de santé en Afrique (International Labour Organization) 953 Health impact assessment: concepts, theory, techniques and applications (Kemm et al) 954 ICF illustration library 550–551 Immunization essentials: a practical field guide (USAID) 709 Immunization financing in developing countries and the international vaccine market: trends and issues (Asian Development Bank) 710–711 Manual of basic techniques for a health laboratory, 2nd edition (WHO) 229 Reproductive health and human rights: integrating medicine, ethics and law (Cook et al) 549 Terrorism and public health: a balanced approach to strengthening systems and protecting people (Levy & Sidel) 72 The vaccine book (Bloom & Lambert) 709–710 Botswana, polio case 394 brain drain 797–798 compensation for African countries 633 health-care workers 560, 595–600, 601–607 nurses 587–594 strategies to discourage 608–615, 616–623 Brazil counters to brain drain 608–615 decentralization and health system performance 822–827 ivermectin mass treatment 563–571 leptospirosis bacterium genome 471–472 poliovirus carrier status in primary immune deficiency disorders 3–8 training health workers to use antimicrobials in childhood illness 509–515 wheezing conditions in early childhood 516–522 breastfeeding HIV-infected mothers 161 promotion and protection 318 bronchiolitis, childhood, global incidence 895–903 burden of disease diabetes in Africa 397–398 pneumonia in young children 895–903 respiratory syncytial virus infection 914–922 typhoid fever 346–353 visual impairment 844–851 Burkina Faso enhancing utilization of health-care services 572–579 infant and child mortality risk factors in rural 265–273 insecticide-treated nets for malaria control 85–91 rare strain of meningitis 398 Byrne, David 889 C Cambodia control of helminthic infections in children 636 immunization through public–private partnership 661–667 simplified screening for thalassaemia and haemoglobin E 364–372 Cameroon, coverage and costs of childhood immunizations 668–675 cardiovascular disease in developing countries 470–471 mortality in Russian Federation 875–880 caregivers, quality of life, in China 493–502 Caribbean region international aid after hurricane devastation 883–884 TRIPS agreement and public health 815–821 cataract global data for 2002 844–851 surgery, cost-effectiveness analysis 338–345 cause of death reporting in developing countries 83 trends and ICD coding changes 904–913 young motherhood as, in developing countries 473 ceftriaxone, maternal syphilis 433–438 cerebrovascular accident see stroke Chagas disease, residual spraying against Triatoma infestans, in Argentina 196–205 chemicals, and child health 814 child health chemicals and 814 environment-related hazards 558 in south-eastern Europe 539–546 child mortality insecticide-treated nets for malaria control and 85–91 latrine revision programme and, in Afghanistan 281–289 Millennium Development Goals 156–157, 804 pneumonia 895–903 risk factors in rural Burkina Faso 265–273 Child public health (Blair et al) 150 childbirth, as cause of death in girls in developing countries 473 children development of new growth standards 718 hand-washing education 631–632 immunization costs of delivery, in Peru 676–682 coverage and costs, in Cameroon 668–675 financial challenges 697–702 through public–private partnership, in Cambodia 661–667 obesity and type 2 diabetes 959 pneumonia incidence 895–903 respiratory syncytial virus infection 914–922 sexual abuse in Africa 313 training health workers to use antimicrobials 509–515 wheezing conditions in young, in Brazil 516–522 zinc as adjunct therapy for diarrhoea 523–531 see also infants China attitudes to family-planning services for unmarried young people 274–280 counters to brain drain 608–615 herbal treatment for jaundice 154 public health-care system 480, 532–538 quality of life in chronic disease and caregivers 493–502 SARS cases 79, 152–153, 394, 470 tuberculosis control using DOTS 716 chlamydia infections effectiveness of condoms in preventing 454–461 women in rural Peru 483–492 chronic disease dependency and dependency ratios worldwide 251–258 mortality in Russian Federation 875–880 new global strategy 556 quality of life, in China 493–502 in south-eastern Europe 539–546 Circles of recovery: self-help organizations for addictions (Humphreys) 390 circumcision, prevention of HIV infection 394–395 civil society organizations (CSOs), participation in health research 757–763 clefts, orofacial, association with maternal smoking in pregnancy 213–218 climate change and human health 79 mortality effects 481 clinical trials James Lind’s paper on scurvy 791–796 registration 321, 397, 714 without ethical review, in India 314 cloning, human, proposed UN treaty 76 Cochrane Collaboration 778–783 communicable diseases antimicrobial resistance containment and surveillance approach 928–934 economics of eradication vs control 683–688 Millennium Development Goals 156–157, 804–805 in south-eastern Europe 539–546 community participation, in health impact assessment 881 compliance, fixed-dose combination pills vs unit-of-use packaging 935–939 condoms contraceptive effectiveness within marriage 180–186 prevention of sexually transmitted infections 454–461 consent, informed, in developing countries 771–777 Continent of mothers. Continent of hope. Understanding and promoting development in Africa today (Skard) 71 contingent valuation survey, demand for AIDS vaccine, in Uganda 652–660 continuing medical education (CME), in India 154–155 contraception within marriage, condoms vs oral contraceptives 180–186 for unmarried young people, attitudes in China 274–280 cost-benefit analysis, health research 733–739 cost-effectiveness analysis cataract surgery 338–345 latrine revision programme, in Afghanistan 281–289 strategies to increase immunization coverage 689–696 supplementary tetanus immunization, in Pakistan 643–651 zinc therapy for childhood diarrhoea 523–531 cost sharing (user fees) and demand for AIDS vaccine, in Uganda 652–660 discontinuation in Uganda 187–195 963Bulletin of the World Health Organization | December 2004, 82 (12) Index costs childhood immunization in Cameroon 668–675 delivery of routine immunization, in Peru 676–682 effective antimalarial drugs in Africa 381–384 post-polio certification immunization policies 9–15 strategies to increase immunization coverage 689–696 cotrimoxazole prophylaxis for infants exposed to HIV infection 290–298 prophylaxis in HIV-positive TB patients in Malawi 354–363 cross-sectoral cooperation, in public health 322 D Danzon, Dr Marc 809–810 Darfur region of Sudan see Sudan, Darfur region DDT, for malaria control 472–473 death certification, and cause-of-death reporting, in developing countries 83 decentralization and health system performance, in Brazil 822–827 deltamethrin residual spraying against Triatoma infestans, in Argentina 196–205 topical mass treatment, in Brazil 563–571 demographic trends see population ageing Denmark, ICD coding changes and cause-specific mortality trends 904–913 dependency and dependency ratios, global trends 251–258 depression, treatment gap 858–866 developed countries economics of disease eradication vs control 683–688 migration of health-care workers to 560, 595–600, 601–607, 634, 797–798 nurse migration to 587–594 strategies to discourage brain drain 608–615, 616–623 see also Group of Eight (G-8) countries developing countries AIDS/HIV 3-by-5 strategy 77–78, 474–476 BBC series on diseases 473 brain drain counter strategies 608–615, 616–623 cardiovascular disease 470–471 condom use within marriage 180–186 death certification and cause-of-death reporting 83 earmarked donor funding 703–708 economics of disease eradication vs control 683–688 economics of vaccination 640, 689–696 financial challenges of immunization and GAVI 697–702 free anti-TB drugs 79 genital herpes and HIV infection 447–453 global public goods concept of genomics knowledge 385–389 health expenditure 957–958 health research in see research (and development), in developing countries HIV serostatus disclosure among women 299–307, 552 immunization through public–private partnership 661–667 implementing “know–do” gap 723, 724–732 information technology in primary health care 867–874 migration of health-care workers from 560, 595–600, 601–607, 634, 797–798 Millennium Development Goals see Millennium Development Goals non-communicable diseases 556 non-profit initiatives tackling neglected diseases 395–396 nurse emigration 587–594 obesity and socioeconomic status 940–946 oral diseases 238 pneumonia in young children 895–903 regulatory pathways for vaccines 128–133 safe blood supplies 558 substance use problems 641 TRIPS agreement and 813, 815–821 vaccine-associated paralytic polio 53–58 young motherhood as cause of death 473 zinc as adjunct therapy for childhood diarrhoea 523–531 diabetes childhood obesity and 959 projected burden in Africa 397–398 diabetic retinopathy, global data for 2002 844–851 diarrhoea hand-washing for prevention 631–632 latrine revision programme, in Afghanistan 281–289 zinc as adjunct therapy, in developing countries 523–531 dichlorophenolindophenol (DCIP) precipitation test, thalassaemia and haemoglobin E screening 364–372 diet, new global strategy 478, 556 disability, global dependency and dependency ratios 251–258 doctors compensation for brain drain of African 633 migration from developing countries 595–600 migration patterns in 1970s 624–630 drug misuse, in developing countries 641 drugs fixed-dose combination vs unit-of-use packaging 935–939 microbial resistance 928–934 priority needs 959 research, health care benefits vs commercial return 74–75 role of patents in R&D 784–790 TRIPS agreement and 813, 815–821 use by indigenous communities in Bolivia 243–250 dysentery, zinc as adjunct therapy, in developing countries 523–531 dysthymia, treatment gap 858–866 E e-Health 800–802 Eastern Mediterranean, religion-based tobacco control 894, 923–927 economic development Millennium Development Goals and 947–952 obesity and socioeconomic status and 940–946 economics antimalarial drugs in Africa 381–384 Arrow’s 1963 paper 139–149 childhood immunization in Cameroon 668–675 congenital syphilis prevention 402–409 demand for AIDS vaccine, in Uganda 652–660 discontinuation of cost sharing in Uganda 187–195 earmarked donor funding 703–708 global infectious disease policies 683–688 global international aid priorities 554–555 health research 733–739 immunization and GAVI 697–702 vaccination, in developing countries 640, 689–696 see also cost-effectiveness analysis; costs education to counter brain drain 608–615 hand-washing, for children 631–632 health researchers in developing countries 764–770 elderly, expanding population, in Lebanon 219–225 environment change see climate change child health and 558 and health 322 epilepsy 889 EQ-5D questionnaire, factors predicting score, in South Africa 206–212 equity genomics knowledge 385–389 immunization through a public–private partnership, in Cambodia 661–667 issues in health research 740–745 Ethical and regulatory aspects of clinical research: readings and commentary (Emanuel et al) 551 ethics clinical trials without ethical review, in India 314 informed consent in developing countries 771–777 MMR safety controversy 311–312 Europe centre for disease control 233 drug-resistant TB 313 health in south-eastern 539–546 HIV epidemic 310–311 ICD coding changes and cause-specific mortality trends 904–913 measles outbreaks 889–890 mental health care treatment gap 858–866 patient evaluations vs WHO measures of achievement 106–114 reporting of adverse events following immunization 828–835 WHO Regional Director 809–810 Evans, Dr Timothy 956–957 evidence-based medicine antenatal care in Thailand 746–749 Cochrane Collaboration 778–783 implementation in clinical practice 724–732 James Lind’s paper on scurvy 791–796 Evidence-based public health (Brownson et al) 308 eye hospitals, rubella serosurveys of female staff, in India 259–264 F family-planning services for unmarried young people, attitudes in China 274–280 female genital mutilation, strategy against, in Mali 153–154 filariasis, control by ivermectin 562 964 Bulletin of the World Health Organization | December 2004, 82 (12) Index financing AIDS programmes 713 China’s health-care system 480, 532–538 health-care services in Afghanistan 712–713 health research in developing countries 764–770 immunization and GAVI 697–702 infectious disease eradication vs control 683–688 Millennium Development Goals 947–952 resource allocation and earmarked donor funding 703–708 Finland, ICD coding changes and cause-specific mortality trends 904–913 Fogarty International Center 616–623 Food fight: the inside story of the food industry, America’s obesity crisis, and what can be done about it (Brownell & Horgen) 308–309 food safety, “five keys” strategy 889 Framework Convention on Tobacco Control 635 France, changes to health care system 232 freezing, hepatitis B vaccine, in Indonesian cold chain 99–105 G gender equity of health research and 162, 740–745 inequalities, and HIV/AIDS control 812 obesity and socioeconomic status and 940–946 see also women genital herpes effectiveness of condoms in preventing 454–461 and HIV infection 447–453 genomics global public goods perspective 385–389 leptospirosis bacterium 471–472 glaucoma global data for 2002 844–851 need for public health action 887–888 Global Alliance for Vaccines and Immunization (GAVI) 697–702 Global Forum for Health Research, 2003 conference 75–76 Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) 237 Global public health: a new era (Beaglehole) 150–151 global warming, effects on mortality 481 gonorrhoea effectiveness of condoms in preventing 454–461 women in rural Peru 483–492 Group of Eight (G-8) countries financing AIDS programmes 713 Global HIV Vaccine Enterprise 557 see also developed countries growth, child, development of new standards 718 Guide de gestion des mutuelles de santé en Afrique (International Labour Organization) 953 Guinea, polio case 717 H haemoglobin E screening in south-east Asia 364–372 Haiti restoration of public health services 316–317 vaccination campaign 398 hand-washing, to prevent diarrhoea in children 631–632 health earmarked donor funding and 703–708 environment and 322 inequalities, tackling 482, 807–808 and migration 561 Millennium Development Goals see Millennium Development Goals sector-wide approach impact 893 social determinants 320, 807–808 in south-eastern Europe 539–546 TRIPS agreement and 813, 815–821 health care adverse effects 889, 892 priority-setting criteria, in Uganda 172–179 health-care services in Afghanistan 712–713 injuries 241 restoration in Haiti 316–317 utilization after discontinuation of cost sharing, in Uganda 187–195 enhancement, in Burkina Faso 572–579 health-care workers attitudes to sexual and reproductive health services for unmarried young people 274–280 migration 560, 595–600, 601–607, 634, 797–798 rubella susceptibility, at three eye hospitals in India 259–264 training to use antimicrobials in childhood illness 509–515 see also doctors; nurses health expenditure, increasing, in developing countries 957–958 health impact assessment, community participation 881 Health impact assessment: concepts, theory, techniques and applications (Kemm et al) 954 health promotion, religion-based 894, 923–927 health systems China 480, 532–538 decentralization and performance, in Brazil 822–827 French, projected changes 232 health research framework for improving 720–721 knowledge-based changes 750–756 Russian Federation, need for reform 391 strengthening 956–957, 959 WHO performance measures, vs patient evaluations 106–114 World health report 2003 78–79 helminthiases control in children in Cambodia 636 control with ivermectin 562, 563–571 hepatitis B vaccine, freezing in Indonesian cold chain 99–105 herbal medicines for jaundice, scientific basis 154 use by indigenous communities in Bolivia 243–250 WHO guidelines 238 herpes simplex virus (HSV), genital effectiveness of condoms in preventing 454–461 and HIV infection 447–453 HIV 3-by-5 initiative for developing countries 77–78, 474–476 drug therapy see antiretroviral therapy economics of international aid 554–555 epidemic, in European Union 310–311 gender inequalities and 812 infected mothers cotrimoxazole prophylaxis for infants 290–298 infant feeding 161 substitute milks for infants 164–171 infection disclosure by women in developing countries 299–307, 552 genital herpes infection and 447–453 natural history in adults in Africa 462–469 Rwandan genocide survivors 472 second-generation surveillance approach 121–127 TB coinfection, cotrimoxazole prophylaxis 354–363 intervention, condom use within marriage 180–186 lessons for congenital syphilis control 431–432 protective effects of circumcision 394–395 topical microbicides for use by women 393–394 treatment programme in South Africa 73–74 and tuberculosis, joint action 810, 890 vaccine determinants of personal demand, in Uganda 652–660 global research and development consortium 557 trial in Thailand 231 World health report 2004 477–478 see also AIDS hospitals, eye, rubella susceptibility of female staff, in India 259–264 human immunodeficiency virus see HIV human papillomavirus (HPV) effectiveness of condoms in preventing 454–461 women in rural Peru 483–492 humanitarian crises challenges of securing health 642 Darfur region of Sudan 233–234, 553–554, 642 region of Uganda neighbouring Darfur 886 see also international aid hunger, economics of international aid 554–555 hurricanes, Caribbean 883–884 hygiene, hand-washing to prevent childhood diarrhoea 631–632 hypertension, in stroke survivors in southern Africa 503–508 I ICF illustration library 550–551 immune deficiency diseases, primary, poliovirus carrier status 3–8 immunization coverage and costs of childhood, in Cameroon 668–675 economics of strategies to increase coverage 689–696 965Bulletin of the World Health Organization | December 2004, 82 (12) Index financial challenges and GAVI 697–702 reporting of adverse events following, in Europe 828–835 through public–private partnership, in Cambodia 661–667 variation in cost of delivery, in Peru 676–682 see also vaccination Immunization essentials: a practical field guide (USAID) 709 Immunization financing in developing countries and the international vaccine market: trends and issues (Asian Development Bank) 710–711 immunoglobulin deficiencies, poliovirus carrier status 3–8 income, quality of life and, in South Africa 206–212 India ban on smoking in public places 473 clinical trials without ethical review 314 continuing medical education (CME) 154–155 counters to brain drain 608–615 de-listing of approved generic AIDS drugs 633, 718 public–private mix for DOTS implementation 580–586 rubella serosurveys at three eye hospitals in Tamil Nadu 259–264 TB in tribal population of Car Nicobar 836–843 Indonesia hepatitis B vaccine freezing in cold chain 99–105 respiratory syncytial virus infection 914–922 infant mortality Millennium Development Goals 804 risk factors in rural Burkina Faso 265–273 infants HIV-infected mothers cotrimoxazole prophylaxis 290–298 feeding 161 recommended replacement milks, in South Africa 164–171 newborn see neonates respiratory syncytial virus infection 914–922 signs and symptoms of illness, in Kenya 323–329 see also children infectious diseases see communicable diseases influenza avian 236–237, 242 pandemics, preparedness for 242, 317–318, 959 information dissemination, Cochrane Collaboration 778–783 information technology in primary health care in developing countries 867–874 public health contribution of e-Health 800–802 informed consent, in developing countries 771–777 injuries, care services 241 insecticide-treated nets (ITNs) for malaria control 84 child mortality impact in West Africa 85–91 longer-lasting 884–886 Integrated Management of Childhood Illness, Multi-Country Evaluation 509–515 intellectual property rights see patents international aid Bam earthquake survivors 156 Caribbean after series of hurricanes 883–884 earmarked donor funding 703–708 global priorities 554–555 Millennium Development Goals and 947–952 in Sudan 233–234, 553–554 International Classification of Diseases (ICD) coding changes, cause-specific mortality trends and 904–913 International Committee of the Red Cross (ICRC), latrine revision programme in Afghanistan 281–289 International Health Regulations 959 International Organization for Migration 561 International Standard Randomised Controlled Trial Number (ISRCTN) register 321, 397 intestinal helminthiases control in children in Cambodia 636 control with ivermectin 562, 563–571 Iran, help for Bam earthquake survivors 156 Iraq, mental health priorities 555 Ireland ban on smoking in workplace 391–392 nurse migration to 587–594 ivermectin adverse effects 562, 566 mass treatment in Brazil 562, 563–571 J jaundice, herbal treatment 154 journals, scientific enhancing health research in developing countries 163, 226–228 gender and poverty and published research 740–745 MMR vaccine safety and publication ethics 311–312 publication of research from developing countries 802–803 US trade embargo ruling 312, 394 K Kenya antenatal syphilis control programme 410–416 public–private mix for DOTS implementation 580–586 signs and symptoms of illness in infants 323–329 “know–do” gap, bridging 723, 724–732, 959 antenatal care in Thailand 746–749 policy development in Thailand 750–756 role of e-Health 800–802 knowledge management, Cochrane Collaboration and 778–783 ownership, patents in pharmaceutical R&D 784–790 L laboratory containment, wild poliovirus 59–66 diagnosis of measles in low-transmission settings 852–857 SARS safety concerns 470 Lao People’s Democratic Republic, thalassaemia and haemoglobin E screening 364–372 Latin America, TRIPS agreement and public health 815–821 latrine revision programme, in Afghanistan 281–289 Lebanon, population ageing 219–225 leprosy, scenario analysis 373–380 leptospirosis, genomics breakthrough 471–472 Liberia, yellow fever emergency 233 life expectancy, smokers 632–633 low-income countries see developing countries M macroeconomics and health, WHO commission 957–958 macular degeneration, global data for 2002 844–851 malaria artemisinin combination therapy see artemisinin combination therapy averting a disaster in Africa 381–384 criticisms of WHO treatment policy 237 DDT for control 472–473 economics of international aid 554–555 insecticide-treated nets for control 84, 85–91, 884–886 monkey, spread to humans 392–393 Malawi, cotrimoxazole prophylaxis in HIV-positive TB patients 354–363 Malaysia, monkey malaria in humans 392–393 Mali female genital mutilation 153--154 polio cases 717 Manual of basic techniques for a health laboratory, 2nd edition (WHO) 229 marital status, family-planning service provision and, in China 274–280 marriage, condom use within 180–186 maternal death infant and child mortality after, in rural Burkina Faso 265–273 new WHO initiative 810 measles laboratory diagnosis in low-transmission settings 852–857 mumps and rubella (MMR) vaccine, safety concerns in UK 311–312 outbreaks in Europe 889–890 prospect for global eradication 134–138 reduction in global death toll 394 mebendazole, mass treatment in Brazil 563–571 media groups, Global Media AIDS Initiative 232–233 medical education, continuing (CME), in India 154–155 medicinal plants use by indigenous communities in Bolivia 243–250 see also herbal medicines men, risk factors for sexual violence against intimate partners 330–337 meningitis, rare strain in Burkina Faso 398 mental health care, treatment gap 858–866 priorities in Iraq 555 research in developing countries, role of scientific journals 226–228 in south-eastern Europe 539–546 two new reports 810 Mexico Ministerial Summit on Health Research (2004) 720–721, 959 poliovirus carrier status in primary immune deficiency disorders 3–8 966 Bulletin of the World Health Organization | December 2004, 82 (12) Index microbicides, topical anti-HIV 393–394 micronutrient deficiencies, global damage assessment 230–231 migration and health 561 health-care workers 560, 595–600, 601–607, 634, 797–798 nurses; trends and policies 587–594 patterns of physicians and nurses in 1970s 624–630 strategies to discourage 608–615, 616–623 milk substitutes, for infants of HIV-infected mothers 164–171 Millennium Development Goals (MDG) achieving 947–952 sanitation targets 234–235 tuberculosis control update 889 updates on progress 156–157, 804–806 mineral deficiencies, global damage assessment 230–231 mortality climate change and 481 statistics, data sources, in developing countries 83 trends, impact of ICD coding changes 904–913 mosquitoes DDT for control 472–473 insecticide-treated nets see insecticide-treated nets (ITNs) for malaria control Mozambique respiratory syncytial virus infection 914–922 secondary prevention of stroke 503–508 N neonates congenital syphilis management 424–430 supplementary immunization to prevent tetanus, in Pakistan 643–651 Nepal, public–private partnership to control TB 92–98 Netherlands, ICD coding changes and cause-specific mortality trends 904–913 Nigeria health research influencing political manifestos 75 polio vaccine safety 313 respiratory syncytial virus infection 914–922 resumption of polio immunization 633, 717 non-profit organizations, tackling neglected diseases 395–396 noncommunicable diseases mortality in Russian Federation 875–880 new global strategy 556 nongovernmental organizations DOTS implementation for TB control 580–586 immunization provision, in Cambodia 661–667 participation in health research 757–763 Norway ICD coding changes and cause-specific mortality trends 904–913 nurse migration to 587–594 Novartis, free anti-TB drug supplies 79 nurses, migration of from developing countries 595–600 patterns in 1970s 624–630 trends and policies 587–594 O obesity childhood 959 and socioeconomic status, in developing countries 940–946 obsessive compulsive disorders (OCD), treatment gap 858–866 opportunistic infections, HIV-infected adults in Africa 462–469 oral contraceptive pill, for contraception within marriage 180–186 oral diseases, in developing countries 238 oral rehydration solutions, cost-effectiveness in developing countries 523–531 organ trafficking and transplantation 715 osmotic fragility (OF) test, thalassaemia and haemoglobin E screening 364–372 P pain relief 889 Pakistan, supplementary tetanus immunization 643–651 Pan American Health Organization (PAHO) measles eradication strategy 852–857 restoration of health services in Haiti 316–317 parallel imports, TRIPS agreement and 815–821 parasitic diseases control in children in Cambodia 636 ivermectin mass treatment 563–571 paratyphoid fever, global burden 346–353 patents genomics knowledge and equity 385–389 role in pharmaceutical R&D 784–790 TRIPS agreement 813, 815–821 patients acceptance of priority-setting criteria, in Uganda 172–179 advocacy, and arthritis 115–120 enhancing health service utilization, in Burkina Faso 572–579 evaluations, vs WHO measures of achievement 106–114 fixed-dose combination pills vs unit-of-use packaging and adherence 935–939 safety 889, 892 penicillin, maternal syphilis 401, 433–438 permethrin, residual spraying against Triatoma infestans, in Argentina 196–205 Peru costs of delivery of routine immunization 676–682 reproductive tract infections in rural women 483–492 pharmaceutical agents see drugs pharmaceutical industry registration of clinical trials 714 role of patents in R&D 784–790 tackling neglected diseases 395–396 photographic competition 636–638 physical activity, new global strategy 478, 556 physicians see doctors plants, medicinal see medicinal plants Plasmodium knowelsi, human cases 392–393 Pneumocystis carinii pneumonia, cotrimoxazole prophylaxis in HIV-exposed infants 290–298 pneumonia childhood, global incidence 895–903 cotrimoxazole prophylaxis in HIV-exposed infants 290–298 policy to counter brain drain 608–615 development in Thailand 750–756 implementing “know–do” gap 724–732 infectious disease eradication vs control 683–688 noncommunicable disease control in Russian Federation 875–880 nurse migration 587–594 religion-based health 923–927 response to health inequalities 482 polio(myelitis) cases in Africa 394, 557, 717 eradication 1 certification process and lessons learned 24–30 economics 683–688 news on progress 157, 237–238, 557 photographs 67–70 volunteers’ contribution 2 post-certification era 1 cost analysis of immunization policies 9–15 framework for evaluating risks of paralytic polio 40–46 immunization strategies in developing countries 53–58 polio control measures 47–52 role of routine vaccination 31–39 vaccination campaigns 237–238, 889, 890 in post-certification era see above resumption in Nigeria 633, 717 vaccine-associated paralytic current state of knowledge 16–23 developing country perspective 53–58 poliovirus carrier status, primary immune deficiency disorders 3–8 circulating vaccine-derived 16–23 containment, and global certification 59–66 poliovirus vaccines inactivated (IPV) cost analysis 9–15 in developing countries 53–58 in post-certification era 31–39, 47–52 production site containment 59–66 oral (OPV) circulating vaccine-derived polioviruses 16–23 cost analysis 9–15 in developing countries 53–58 in post-certification era 31–39, 47–52 safety, in Nigeria 313 population ageing global dependency and dependency ratios and 251–258 in Lebanon 219–225 postmarketing surveillance, vaccines 828–835 967Bulletin of the World Health Organization | December 2004, 82 (12) Index poverty equity of health research and 740–745 progress on Millennium Development Goals 804–805 pregnancy care during see antenatal care as cause of death in girls in developing countries 473 maternal smoking and orofacial clefts 213–218 syphilis during 401 in AIDS/HIV era 431–432 case studies 410–416 economic and programmatic aspects 402–409 overview and recommendations 424–430 pathophysiology and treatment 433–438 people, programmes, policies and politics 417–423 primary health care health information technology, in developing countries 867–874 patient evaluations, vs WHO performance measures 106–114 training health workers to use antimicrobials in childhood illness 509–515 priority setting, stakeholder values in Uganda 172–179 public–private partnerships to control TB, in Nepal 92–98 DOTS implementation for TB control 580–586 to improve immunization equity, in Cambodia 661–667 tackling neglected diseases 395–396 public goods, global, genomics knowledge as 385–389 public health, cross-sectoral cooperation 322 pyrethrins, residual spraying against Triatoma infestans, in Argentina 196–205 Q quality of health care, patient evaluations vs WHO measures 106–114 quality of life chronic diseases and caregivers in China 493–502 determinants, in South Africa 206–212 R randomized controlled trials registration 321, 397, 714 see also clinical trials refractive errors, global data for 2002 844–851 refrigeration, hepatitis B vaccine, in Indonesian cold chain 99–105 registration, clinical trials 321, 397, 714 religion, in tobacco control interventions 894, 923–927 reproductive health landmark global strategy 478 services for unmarried young people, attitudes in China 274–280 Reproductive health and human rights: integrating medicine, ethics and law (Cook et al) 549 reproductive tract infections, rural women in Peru 483–492 research (and development) brain drain counter strategies 608–615, 616–623 civil society perspective 757–763 in developing countries 722, 764–770 informed consent 771–777 publication in international health literature 802–803 role of journals in enhancing 163, 226–228 estimating economic value 733–739 framework for improving health systems 720–721 gender and poverty issues 740–745 gender issues and 10/90 gap 162 Global Forum for Health Research, 2003 conference 75–76 health care benefits vs commercial return 74–75 implementing “know–do” gap 723, 724–732 antenatal care in Thailand 746–749 policy development in Thailand 750–756 influencing political manifestos in Nigeria 75 James Lind’s paper on scurvy 791–796 registry of randomized controlled trials 321, 397, 714 role of patents in pharmaceutical 784–790 synthesis and dissemination by Cochrane Collaboration 778–783 US trade embargo ruling on publishing 312, 394 see also clinical trials resource allocation, earmarked donor funding and 703–708 respiratory infections, acute respiratory syncytial virus 914–922 in young children 895–903 respiratory syncytial virus (RSV) infection, in four developing countries 914–922 respiratory tract diseases, in early childhood, in Brazil 516–522 “River of Life” international photograph competition 636–638 road traffic injuries new report 240 world report 315–316 Rotary International, role in polio eradication 2 rubella, serosurveys at three Aravind Eye Hospitals in India 259–264 rural areas China’s health-care system 532–538 enhancing utilization of health-care services, in Burkina Faso 572–579 immunization through public–private partnership, in Cambodia 661–667 infant and child mortality risk factors, in Burkina Faso 265–273 reproductive tract infections in women in Peru 483–492 residual spraying against Triatoma infestans, in Argentina 196–205 thalassaemia and haemoglobin E screening 364–372 Russian Federation ailing health-care system 391 noncommunicable disease mortality 875–880 Rwanda, HIV infection of genocide survivors 472 S Samba, Dr Ebrahim 717–718, 809 Sambo, Dr Luis 809 sanitation latrine revision programme in Afghanistan 281–289 progress towards global targets 234–235 SARS (severe acute respiratory syndrome) cases in China 79, 152–153, 394, 470 China’s health-care system and 532–538 laboratory safety 470 vaccine development 153 virus, changing virulence 547–548 scenario analysis, leprosy 373–380 schizophrenia, treatment gap 858–866 scurvy, James Lind’s original paper 791–796 sector-wide approach (SWAp) 893 severe acute respiratory syndrome see SARS sex see gender sex education, for unmarried young people, attitudes in China 274–280 sexual abuse, women and children in Africa 313 sexual violence, against intimate partners, in South Africa 330–337 sexually transmitted infections (STIs) effectiveness of condoms in preventing 454–461 women in rural Peru 483–492 skin diseases, parasitic, control with ivermectin 563–571 smallpox eradication 683–688 smoking, tobacco bans in public places 391–392, 473 in developing countries 641 impact on life expectancy 632–633 in pregnancy, association with orofacial clefts 213–218 see also tobacco control social determinants of health 320, 807–808 socioeconomic status childhood immunization coverage and, in Cameroon 668–675 equity of health research and 740–745 and obesity, in developing countries 940–946 quality of life and, in South Africa 206–212 South Africa antenatal syphilis control programme 410–416 determinants of quality of life 206–212 HIV/AIDS treatment programme 73–74 replacement milks for infants of HIV-infected mothers 164–171 respiratory syncytial virus infection 914–922 secondary prevention of stroke 503–508 sexual violence against intimate partners 330–337 South-East Asia, thalassaemia and haemoglobin E screening 364–372 Southern Africa Stroke Prevention Initiative (SASPI) study 503–508 stakeholders syphilis control programmes 417–423 see also patients stroke, secondary prevention in southern Africa 503–508 strongyloidiasis, control by ivermectin 562 substance use problems in developing countries 641 treatability 318 Sudan, Darfur region crisis in neighbouring region of Uganda 886 humanitarian crisis 233–234, 553–554, 642 mortality rates 809 polio case 557 968 Bulletin of the World Health Organization | December 2004, 82 (12) Index surveillance antimicrobial resistance 928–934 second-generation approach to HIV 121–127 Sweden, ICD coding changes and cause-specific mortality trends 904–913 syphilis congenital 401 antenatal control; people, programmes, policies and politics 417–423 case studies of control programmes 410–416 control in HIV/AIDS era 431–432 diagnostic tools for preventing 439–446 economic and programmatic aspects of prevention 402–409 recommendations for prevention and management 424–430 effectiveness of condoms in preventing 454–461 maternal diagnostic tools for managing 439–446 pathophysiology and treatment 433–438 women in rural Peru 483–492 T Tanzania see United Republic of Tanzania Terrorism and public health: a balanced approach to strengthening systems and protecting people (Levy & Sidel) 72 tetanus, supplementary maternal immunization in Pakistan 643–651 Thailand antenatal care 746–749 bridging the “know–do” gap 723 HIV/AIDS vaccine trial 231 International Conference on Health Research for Development (2000) 720–721 policy development 750–756 thalassaemia and haemoglobin E screening 364–372 thalassaemia screening in south-east Asia 364–372 3-by-5 strategy, to combat AIDS/HIV in developing countries 77–78, 474–476 tobacco control bans on smoking in public places 391–392, 473 religion-based interventions 894, 923–927 WHO Framework Convention 635 toilet facilities, revision programme, in Afghanistan 281–289 trachoma, global data for 2002 844–851 Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement 813, 815–821 traditional medicine guidelines 635–636 use by indigenous communities in Bolivia 243–250 training health researchers in developing countries 764–770 health workers to use antimicrobials in childhood illness 509–515 transplantation, and organ trafficking 715 trauma care 241 Triatoma infestans, residual spraying in Argentina 196–205 trichomoniasis effectiveness of condoms in preventing 454–461 women in rural Peru 483–492 trimethoprim-sulfamethoxazole see cotrimoxazole tuberculosis (TB) control using DOTS, in China 716 drugs see anti-tuberculous drugs duration of protection by BCG vaccine 555 and HIV joint action 810, 890 HIV-positive patients with, cotrimoxazole prophylaxis, in Malawi 354–363 public–private mix for DOTS implementation 580–586 public–private partnership to control, in Nepal 92–98 in tribal population of Car Nicobar, India 836–843 twins, mortality in rural Burkina Faso 265–273 typhoid fever, global burden 346–353 U Uganda crisis in region neighbouring Darfur 886 determinants of personal demand for AIDS vaccine 652–660 discontinuation of cost sharing 187–195 natural history of HIV infection 462–469 setting priorities for health care 172–179 training health workers to use antimicrobials in childhood illness 509–515 UNAIDS joint HIV-TB action 810 recommended replacement milks for infants of HIV-infected mothers 164–171 United Kingdom (UK) ICD coding changes and cause-specific mortality trends 904–913 MMR vaccine safety controversy 311–312 nurse migration to 587–594 poliovirus carrier status in primary immune deficiency disorders 3–8 United Nations (UN) Global Media AIDS Initiative 232–233 Millennium Development Goals 947–952 proposed treaty on human cloning 76 United Nations Children’s Fund (UNICEF) promotion of breastfeeding 318 recommended replacement milks for infants of HIV-infected mothers 164–171 United Republic of Tanzania training health workers to use antimicrobials in childhood illness 509–515 zinc as adjunct therapy for childhood diarrhoea 523–531 United States (USA) HIV/AIDS vaccine trial in Thailand and 231 nurse migration to 587–594 poliovirus carrier status in primary immune deficiency disorders 3–8 strategies to discourage brain drain 616–623 trade embargo affecting scientific publishing 312, 394 universal coverage, implementation in Thailand 750–756 urban areas, public–private partnership to control TB 92–98 user fees see cost sharing V vaccination campaign, in Americas 398 economics, in developing countries 640, 689–696 see also immunization The vaccine book (Bloom & Lambert) 709–710 vaccines for developing countries, regulatory pathways 128–133 reporting of adverse reactions, in Europe 828–835 vaginal discharge, women in rural Peru 483–492 Viet Nam, public–private mix for DOTS implementation 580–586 visual impairment, global data for 2002 844–851 vitamin deficiencies, global damage assessment 230–231 voluntary sector, role in polio eradication 2 W wars and conflicts humanitarian crisis in Sudan 233–234, 553–554 mental health priorities in Iraq 555 restoration of health services, in Haiti 316–317 wheezing conditions in early childhood, in Brazil 516–522 WHO Quality of Life questionnaire (WHOQOL-100), chronic disease and caregivers in China 493–502 women discrimination against, and HIV/AIDS control 812 equity of health research and 740–745 HIV infection in Rwandan genocide survivors 472 HIV serostatus disclosure in developing countries 299–307, 552 obesity and socioeconomic status, in developing countries 940–946 reproductive tract infections in rural Peru 483–492 rubella susceptibility, eye hospital staff in India 259–264 sexual abuse in Africa 313 sexual violence by intimate partners, in South Africa 330–337 supplementary tetanus immunization, in Pakistan 643–651 topical anti-HIV microbicides 393–394 World Alliance for Patient Safety 889, 892 World Health Assembly 2004 478 World Health Organization (WHO) certification of polio eradication 24–30 health system performance measures, vs patient evaluations 106–114 World health report 2003 78–79 World health report 2004 477–478 World Report on Knowledge for Better Health: Strengthening Health Systems 959 World report on road traffic injury prevention (WHO and World Bank) 240, 315–316 World Trade Organization (WTO) 813, 815–821 Y yellow fever, emergency in Liberia 233 young people, unmarried, attitudes to provision of sexual and reproductive health services, in China 274–280 Z Zimbabwe, red AIDS ribbon banned 633 zinc, as adjunct therapy for childhood diarrhoea 523–531 zoonoses, role of human behaviour in emergence 478 969Bulletin of the World Health Organization | December 2004, 82 (12) Author Index A Abrahams, N 330 Adams, A 24 Adams, O 560, 595 Afadapa, N 424 Agnew, B 231 Agol, VI 16 Ahmad, K 712–713 Ahmad, OB 797 Ahun, M 709 Ainsworth, M 652 Albrecht, S 563 Ali, MM 180 Allan, R 381 Allegranzi, B 928 Alonso, P 914 Amaral, J 509 Antes, G 321 Anuradha, R 259 Arora, VK 580 Arrow, KJ 141 Asamoah-Odei, E 121 Aschwanden, C 76 Asturias, E 3 Asudani, D 552 Atkinson, S 822 Attaran, A 788 Aylward, RB 40 Azais, B 788 B Bach, S 624 Bailey, C 798 Bale, HE 788 Baltussen, R 338 Bam, DS 92 Banerji, D 707 Banken, R 308 Baral, SC 92 Barrett, S 683 Barton, JH 787 Batt, K 689 Baum, F 757 Baydoun, M 219 Beaglehole, R 72 Becher, H 265 Belgharbi, L 128 Bellini, W 852 Benicio, MHD’A 516 Berdichevsky, K 802 Berman, P 710–711 Berman, SM 433 Bermudez, JAZ 815 Bertollini, R 322, 814 Best, M 59 Bhushan, I 661 Bhutta, ZA 771 Bishai, D 652 Black, RE 523 Blanco, S 196 Block, MAG 732 Bocar, K 572 Boerma, WGW 106 Borchert, M 724 Boschi-Pinto, C 895 Braine, T 883–884 Brenzel, L 640 Bridbord, K 616 Broutet, N 410, 431 Brown, D 259 Bryce, J 509 Buchan, J 587 Burgess, C 381 Burke, DS 668 Burnham, GM 187 Buse, K 417 Buxton, M 733 C Cáceres, VM 9, 31 Calewaert, J-B 243 Campbell, H 150, 895 Canale, DM 196 Cárcamo, C 482 Cardoso, MRA 516 Cardy, A 213 Carrasco, P 852 Carrin, GJ 950, 953 Castillo-Riquelme, M 689 Celum, C 447 Chaisiri, K 746 Chakraborty, AK 836 Chalmers, I 791 Chaves, GC 815 Chavez, S 483 Chepng’eno, G 572 Chiappe, M 483 Child Health Epidemiology Reference Group, WHO 895 Chongsomchai, C 746 Chopra, M 757 Chowdhury, M 881 Clark, AD 676 Cleland, J 180 Cochi, SL 9, 40 Collinson, M 914 Conde, WL 940 Connor, J 935 Correa, CM 784 Corser, J 552 Corvalan, CF 481 Cousens, SN 85 Crabb, C 154, 232 Crampin, AC 354 Crump, JA 346 Cui, N 274 Cuzin-Ouattara, N 85 D Da Silva, E 3 Daar, AS 385 Dal Poz, M 595 Dallabetta, G 121 Dangwibul, S 364 Danzon, M 814 Davids, A 812 De Castro, LD 551 De jonckheere, S 243 De Kimpe, N 243 De Quadros, CA 134 De Sarkar, B 154–155 Delpeyroux, F 16 Dennis, R 764 Department of Mental Health and Substance Abuse, WHO 226 Deperthes, BD 410 Deshpande, JM 64 Diallo, DA 85 Diallo, K 595, 601 Díaz-Olavarrieta, C 802 Dietz, V 852 Donaldson, L 892 Dong, H 572 Dougherty, L 668 Dovlo, D 620 Dowdle, WR 59 Doyal, L 162 Dunn, G 3 Durrheim, D 562 Dyer, O 714 E Editors of journals publishing mental health research 226 El Awa, F 894 Elliot, J 229 English, M 323 Espinosa-Rosales, F 3 Esposito, F 85 Etya’ale, D 844 Euller-Ziegler, L 115 Evans, T 956 F Facchini, LA 867 Fathalla, MF 722 Faure-Fontenla, MA 3 Feldmeier, H 563 Ferguson, G 206 Feringa, B 483 Ferreira, MU 516 Fine, PEM 47, 354 Fleck, F 75–76, 77–78, 152–153, 232–233, 236–237, 311–312, 314, 392–394, 470–471, 555, 631–632, 634 Floyd, S 354 Fontaine, O 509 Fouad, FM 923 Fox-Rushby, JA 640, 676, 689 Fucharoen, G 364 Fucharoen, S 364 G Galiwango, E 187 Gao, E 274 García, PJ 483 Garcia-Moreno, C 299 Garrison, C 789 Gbangou, A 265 Gee, VT 322 George, A 740 Gill, CJ 290 Glynn, JR 354 Goga, Y 424 Gold, ER 385 Goosen, J 241 Gopi, PG 836 Gouws, E 509 Graham, SM 297 Grant, AD 462 Griffiths, UK 643 Groenewegen, PP 106 Grondin, D 561 Gülmezoglu, AM 778 Gürtler, RE 196 H Habbema, JDF 373 Habicht, J-P 509 Hafiz, RA 643 Haines, A 724 Halsey, NA 3 Hamer, DH 290 Hanney, S 733 Haran, D 822 Harries, AD 354 Harwood, RH 251 Hawkes, S 417 Henderson, P 161 Heukelbach, J 563 Heymann, DL 1 Hill, K 652 Hirschfeld, M 251 Hoffman, M 330 Hofman, K 616 Holmes, KK 454, 483 Hu, T-w 480 Hussain, H 3 Hutton, G 893 Hyder, AA 240 I IJsselmuiden, C 720 Ilboudo-Sanogo, E 85 Irwin, A 482 Izurieta, H 852 J Jabbour, S 923 Jaffar, S 462 Jahn, A 265 Jansen, KU 483 Janssen, F 904 Jarawan, R 616 Jelsma, J 206 Jewkes, R 330 John, TJ 53 Jolly, AM 547 Jones, T 733 Joshipura, M 241 Juvekar, S 580 K Kaddar, M 640, 697 Kanyongoloka, H 354 Kapiriri, L 172 Kapp, C 472–473 Kartasasmita, CB 914 Kasimba, S 354 Kassak, K 882 Keeton, C 313 Kerr-Pontes, LRS 563 Kerssens, JJ 106 Kew, OM 3, 16 Khan, AJ 3 Kilpi, T 828 Kim, JY 474 Kingman, S 312, 632–633, 887–888 Kocur, I 844 Kohn, R 858 Kolappan, C 836 Koller, T 642 Konno, SC 516 Kouyate, B 265 Kumar, S 154–155 Kunst, AE 904 Kupfer, L 616 Kuruvilla, S 724 Kwankam, SY 800 Kynast-Wolf, G 265 L Labonte, R 757 Lago, PM 31 Lambert, S 59 Lan, NTN 580 Lanata, CF 676 Langer, A 549, 802 Lankinen, KS 828 Lansang, MA 764 Laubsher, R 330 Lazzari, S 121, 242, 928 Leisenfeld, O 563 Leke, R 24 Lengeler, C 84 Leong, AL 115 Lethbridge, J 623 Levav, I 858 Levine, R 447, 454, 640, 697 Levintova, M 875 Li, L 493 Li, W 483 Lincetto, O 424 Lind, J 793 Little, J 213 Liu, Y 532 Long, K 668 Lönnroth, K 580 Lou, C 274 970 Bulletin of the World Health Organization | December 2004, 82 (12) Author Index Luby, SP 346 Lumbiganon, P 746 Lydon, P 697 M Mahoney, RT 709–710 Maia, MFS 867 Majiyagbe, J 2 Mäkelä, PH 828 Malema, S 354 Malla, P 92 Maman, S 299 Mandelbaum-Schmid, J 153–154, 230–231, 391–392, 395–396, 472, 554–555 Mansyur, I 99 Marion, S 281 Mariotti, SP 338, 844 Marmot, MG 320 Marshall, SJ 67, 73–74, 234–235, 310–311, 474–476, 553–554, 556 Martineau, T 622 Martines, J 161 Massarani, L 471–472 Mbewu, AD 400 McDermott, J 616 McGill, S 299 McKee, M 539 Meddings, DR 281 Medley, A 299 Meheus, A 410 Meima, A 373 Mejia, A 626 Melgaard, B 723 Miaka, C 381 Miller, S 417 Milne, I 791 Milstien, J 128 Minor, P 3 Mintz, ED 346 Miranda, JF 608 Mock, C 241 Momen, H 163 Moniaga, V 99 Monteiro, CA 516, 940 Moore, P 807–808 Mosqueira, NR 676 Moura, EC 940 Muehlen, M 563 Mugisha, F 572 Müller, O 265 Mullick, S 431 Munger, RG 213 Murhekar, MV 836 Musani, A 642 Musgrove, P 706 Mutabingwa, TK 381 Mwalekwa, L 323 Mwaniki, D 580 Mwaungulu, FBD 354 Mwita, M 381 N Nabarro, D 642 Nakyanzi-Mugisha, MV 381 Narendran, K 259 Nathanson, N 16 Nayyar, A 417 Ndowa, F 431 Nebié, I 85 Nelson, CM 99 Netherlands Epidemiology and Demography Compression of Morbidity Research Group (NEDCOM) 904 Newell, JN 92 Ngama, M 323 Nitayaramphong, S 750 Nohynek, H 828 Norheim, OF 172 Novotny, T 875 Nullis-Kapp, C 715, 804–805, 886, 957–958 O Oblapenko, G 47 Obot, I 390 Ochola, S 381 Odaibo, GN 914 Olaleye, DO 914 Olin, P 828 Oliveira, MA 815 Oloo, A 381 Oppliger, A 281 O’Reilly, K 410 Östlin, P 740 P Pablos-Mendez, A 720 Page, SW 955 Pallansch, MA 3, 16 Pande, SB 92 Pang, T 720 Papathakis, PC 164 Pararajasegaram, R 844 Pariyo, G 187, 509, 652 Pascolini, D 844 Pastila, S 828 Patel, RS 552 Pathania, V 580 Patz, JA 481 Peeling, RW 439 Penny, ME 676 Peshu, N 323 Philip, P 892 Pinera, JF 281 Pinto, J 3 Pokharel, GP 844 Polio Project Team 3 Popkin, BM 940 Powles, J 150–151 Prajna, L 259 Prakash, K 259 Premji, Z 381 Purwanto, H 99 Q Quddus, A 643 R Rafter, N 935 Ravindran, M 259 Rechel, B 539 Rehle, T 121 Reichenbach, L 417 Resnikoff, S 844 Richardus, JH 373 Robberstad, B 523 Robertson, K 778 Robertson, SE 259, 914 Roca, A 914 Rodgers, A 935 Rollins, NC 164 Ronald, LA 281 Rota, J 852 Rudan, I 895 Ruger, JP 951 S Sabatinelli, G 642 Sabin, LL 290 Sachs, JD 947 Sae-ung, N 364 Sales de Oliveira, FA 563 Salisbury, DM 57 Salomón, OD 196 Saloojee, H 424 Sanca, S 243 Sanchaisuriya, K 364 Sanders, D 757, 952 Sanders, R 59 Sanderson, CFB 676 Sangrujee, N 9 Saraceno, B 858 Saravia, NG 608 SASPI project team 503 Sauerborn, R 572 Savedoff, WD 139, 950 Saxena, P 219 Saxena, S 390, 858 Sayer, AA 251 Schatzmayr, HG 65 Schellenberg, JA 509 Schmid, G 402 Schmid, K 621 Schoub, BD 63 Schwalbe, N 539 Schwartz, JB 661 Segura, EL 196 Sehgal, SC 836 Semo, L 243 Sen, G 740 Sen, K 219 Shah, IH 180 Shimizu, H 16 Shisana, O 812 Shukshin, A 391 Sibai, AM 83, 219 Siegfried, N 778 Simoes, EAF 914 Simonsen, GS 928 Singer, PA 385 Sixma, HJ 106 Smith, J 24 Smith, PG 462 Smith, RD 385 Smith, WCS 373 So, AD 813 Sochalski, J 587 Sommerfelt, H 523 Speare, R 562 Spillmann, C 196 Stariolo, R 196 Steen, R 424 Stilwell, B 560, 595 Stöhr, K 242 Strand, T 523 Sunman, H 707 Sutch, S 550–551 Sutter, R 3 Sutter, RW 31, 47 Sylla, M 338 T Talbot, EA 928 Tangcharoensathien, V 750 Tangermann, RH 24 Tanner, M 893 Tapsall, JW 928 Tegang, S-P 668 Temmerman, M 431 Tham, J 290 Thorsteinsdóttir, H 385 Tomasi, E 867 Tomaskovic, L 895 Tran, N 668 Tu, X 274 Turnbull, P 71–72 Twisselmann, B 71 U Uchtenhagen, A 641 Uplekar, M 580 Utzinger, J 954 V Van Damme, P 243 Van der Eijk, I 106 Van Loon, AM 63 Van Oortmarssen, GJ 373 Van Puyvelde, L 243 Vandebroek, I 243 Vega, J 482 Velaphi, S 424 Velásquez, G 815 Venter, M 914 Vijayalakshmi, P 259 Villar, J 802 Volmink, J 778 Vonhm, B 381 Vujicic, M 595 W Wabwire-Mangen, F 187 Waddington, C 703 Wald, A 447 Walgate, R 74–75 Walker, D 676 Walker, DG 401 Walker, GJA 401 Wang, M-D 547 Waters, HR 668 Weaver, M 447, 454 Webster, ADB 3 Whelan, A 619 Whittle, H 462 Whitty, CJM 381 Whitworth, J 462 Wibisono, H 99 Wibulpholprasert, S 750 Widjaya, A 99 Wilcke, T 563 Winijakul, N 746 Winkelstein, J 3 Winter, B 563 Wise, J 884–886 Wiseman, V 381 Wiysonge, CS 668 Wolfe, ND 668 Wolff, C 59 Wolfson, LJ 643 Wright, PF 16, 914 X Xiao, S 493 Y Yach, D 308–309 Ye, H 431, 439 Young, D 493 Younus, M 643 Z Zhou, L 493 Zhou, X 493 Zhu, Y 914 Zipperer, M 713 Zurn, P 595